STAT

Scientists still don’t know what gives ketamine its antidepressant effect. Stressed mice might offer a clue

The biology behind ketamine’s antidepressant effects has long been a mystery. Could research on stressed mice offer insight into why it’s working?
Source: Teresa Crawford/AP

As ketamine makes waves in the field of mental health, there’s a mystery around the drug that continues to elude scientists: how, exactly, it works in the brains of people with depression.

Now, scientists have uncovered a process that might contribute to ketamine’s antidepressant effect. In new research in mice published Thursday in Science, researchers report that ketamine appears to spark the growth of neural connections that had been diminished by chronic stress. They also discovered that the survival of those new connections — known as synapses — seems to be critical to maintaining some of ketamine’s effects.

“To the extent that what we’re modeling in the brains of mice captures something that’s happening in the brains of depressed people, this could

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks